Randomised induction and post induction therapy in older patients (greater than or equal to 61 years of age) with Acute Myelocytic Leukaemia (AML) and Refractory Anaemia with Excess of Blasts (RAEB, RAEB-t) Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Randomised induction and post-induction therapy in adult patients (less than or equal to 60 years of age) with acute myelocytic leukaemia (AML) or refractory anaemia with excess of blasts (RAEB, RAEB-t) with IPSS score greater than or equal to 1.5 Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Treatment of acute lymphoblastic leukemia (ALL) in adults age 40 - 70 years inclusive with chemotherapy including a "pre-induction course" for rapid tumor load reduction and prolonged maintenance chemotherapy Background and study aims Acute lymphoblastic leukaemia (ALL) is a type of cancer that affects the white blood cells. The outcome of treatment in adults is much worse than in children. The long-term s...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Randomised phase III study in elderly patients with a multiple myeloma on the value of Thalidomide added to Melphalan plus Prednisone Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Feasibility study using repeated intensive chemotherapy courses for patients with primary acute lymphoblastic leukemia in adults age 18 - 39 years inclusive Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A randomised phase III study of intravenous (i.v.) zoledronate (administered for 12 versus 36 months) as an adjunct to standard therapies in the treatment of multiple myeloma Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Early intensification by (un)-related allogeneic or autologous stem cell transplantation in adult Acute Lymphoblastic Leukaemia: a phase II study Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A randomised phase III study of chimeric anti-CD20 monoclonal antibody (rituximab) with two-weekly CHOP chemotherapy (CHOP 14) in elderly patients with intermediate or high-risk non-Hodgkin’s lymphoma Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Autologous stem cell transplantation for patients with amyloid light chain (AL) amyloidosis Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Myelo-ablative chemo/radiotherapy and autologous stem cell transplantation as compared to only chemotherapy in patients with multiple myeloma Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune